摘要
目的探究复方贞术调脂胶囊(FTZ)干预下调控促分裂原活化蛋白激酶激酶激酶2(mitogen-activated protein kinase kinase kinase 2,MEKK2)-Wnt偶联拮抗β-catenin泛素化,及对骨量变化、细胞成骨能力的影响。方法 SPF级雄性大鼠随机均分为正常对照组、甲强龙组(模型组)、甲强龙+生理盐水组(空白对照组)和甲强龙+FTZ组(实验组)。分别对股骨近端松质骨进行Micro-CT检查、组织病理染色,测定Wnt3a、MEKK2、β-catenin蛋白表达;提取模型BMSCs,经FTZ含药血清干预后,进行碱性磷酸酶和茜素红染色;测定成骨分化相关基因ALP、Runx2、OCN表达;测定MEKK2、β-catenin蛋白表达;以及β-catenin/TCF转录水平。结果 1)在Micro-CT中,实验组与模型组相比,前者BV/TV、Tb.Th、Tb/N等值降低,Tb/sp升高(P<0.05)。ROI三维重建可见实验组骨小梁骨质改善,局部性修复;2)经苏木精-伊红染色中,实验组可见骨小梁密度较模型组高、骨小梁形态较好;3)实验组骨组织中Wnt3a、MEKK2、β-catenin表达较模型组增加(P<0.05);4)GIOP大鼠模型提取BMSCs并予BMP2诱导,经FTZ含药血清(实验组)干预后,碱性磷酸酶和茜素红染色结果提示实验组成骨反应增强(P<0.05);5)BMSCs经FTZ含药血清干预,可提高β-catenin/TCF转录活性(P<0.05);促进β-catenin、MEKK2蛋白表达(P<0.05)。结论FTZ通过调控MEKK2-Wnt偶联拮抗β-catenin泛素化防治GIOP,从而改善微观骨性结构。
Objective To establish a rat model of glucocorticoid-induced osteoporosis( GIOP) and to explore the interventional effect of the Chinese medicine Fufang Zhenzhu Tiaozhi( FTZ) capsules on regulation of mitogen-activated protein kinase kinase kinase 2( MEKK2)-Wnt coupling and inhibiting β-catenin ubiquitination,and to investigate the effect of FTZ on the bone mineral density and cell osteogenic ability. Methods SPF male rats were randomly divided into normal control group,methylprednisolone group( model group),methylprednisolone + saline group( blank control group)and methylprednisolone + FTZ group( experimental group). The proximal femoral cancellous bone was examined by micro-CT and histopathology,and assessment of expressions of Wnt3a,MEKK2,and β-catenin proteins. Bone mesenchymal stem cells( BMSCs were isolated and treated with serum containing FTZ,stained by alkaline phosphatase and alizarin red.The expressions of osteogenic differentiation-related genes ALP,Runx2 and OCN,the expressions of MEKK2 and β-catenin proteins,and the transcription level of β-catenin/TCF were determined. Results 1) The micro-CT imaging showed that compared with the control group,the BV/TV,Tb. Th and Tb/N expressions were significntly decreased,and Tb/sp increased in the experimental group( P〈0. 05). Region of interest( ROI) three-dimensional reconstruction of trabecular bone in the experimental group showed improvement of bone trabeculae and local bone repair. 2) The pathology using hematoxylin and eosin staining showed that in the experimental group,the bone trabecular density was higher than that of the model group,and observed a better trabecula morphology. 3) The Wnt3a,MEKK2 and β-catenin expressions in the experimental group were significantly increased compared with the model model( P〈0. 05). 4) After treated with FTZ and BMP2,the result of alkaline phosphatase and alizarin red staining indicated an enhanced osteogenic response( P〈0. 05)in the GIOP rat models. 5) After treatment with seum containing FTZ,The BMSCs isolated from the GIOP rats enhanced the transcriptional activity of β-catenin/TCF/LEF( P〈0. 05) and promoted the expression of β-catenin and MEKK2 proteins( P〈0. 05). Conclusions FTZ can ameliorate GIOP by regulating the MEKK2-Wnt coupling and inhibiting the β-catenin ubiquitination,and improve the bone microstructure.
作者
洪郭驹
陈鹏
韩晓蕊
何伟
孙平
HONG Guoju;CHEN Peng;HAN Xiaorui;HE Wei;SUN Ping(National Key Laboratory of Key Discipline and the Chinese Medicine Orthopedics, Medical Center of Southern China of Guangzhou University of Chinese Medicine, Guangzhou 510405, China;Department of Othpeadies, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405;School of Biomedical Science, the University of Western Australia, Perth, 6009, Australia;Radiographic Department of Radiology, Guangzhou First's Hospital, Guangzhou 510006;Department of Othpeadics, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510000)
出处
《中国实验动物学报》
CAS
CSCD
北大核心
2018年第1期36-44,共9页
Acta Laboratorium Animalis Scientia Sinica
基金
广州中医药大学2017年度"高水平大学建设"青年项目(No.A1-AFD018171Z11076)
国家自然科学基金项目(青年科学基金)(No.81603641
No.81704098)~~
关键词
糖皮质激素性骨质疏松
复方贞术调脂胶囊
MICRO-CT
BMSCS
成骨
glucocorticoid-indaced osteoporosis
Fufang Zhenzhu Capsule(a Chinese medicine)
micro-CT
bone mesenchymal stem cells
BMSCs
osteogenesis
rat